4 news items
InflaRx Hosts R&D Event Highlighting the Promise of INF904
IFRX
5 Jun 24
during which the results of the trials will become available, the costs of such trials and our research and development programs generally; our
InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators
IFRX
21 May 24
of such trials and our research and development programs generally; our interactions with regulators regarding the results of clinical trials and potential
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
IFRX
8 May 24
, 2024InflaRx will host a virtual research and development event on June 5, 2024. Guided by internationally renowned thought
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
IFRX
24 Apr 24
of the trials will become available, the costs of such trials and our research and development programs generally; our interactions with regulators
- Prev
- 1
- Next